Seretide Competition Builds Up But Substitutability Holds Key?

More possible competition is building for GlaxoSmithKline's blockbuster salmeterol and fluticasone combination, with a second Indian firm teaming up with the Polish biopharmaceutical company Celon to produce a version of the product.

More from Respiratory

More from Therapy Areas